A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis Meeting Abstract
| Authors: | Yu, K.; Mantha, S.; Tjan, C.; Kaufmann, E.; Brenner, R. B.; Lowery, M.; Ku, G.; Raj, N.; Shcherba, M.; Goldberg, Z.; Li, J.; Zervoudakis, A.; Hamilton, A.; Won, E.; Do, R. K. G.; O'Reilly, E. M. |
| Abstract Title: | A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy287.002 |
| Language: | English |
| ACCESSION: | WOS:000459277301309 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy282.113 |
| Notes: | Meeting Abstract: 730P -- Appears on page viii248 of the abstract book -- Source: Wos |
